RÉSUMÉ
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80% Caucasian men and 42% of women. Patients afflicted with androgenetic alopecia may undergo significant impairment of quality of life. The European Dermatology Forum (EDF) initiated a project to develop evidence-based guidelines for the treatment of androgenetic alopecia. Based on a systematic literature research the efficacy of the currently available therapeutic options was assessed and therapeutic recommendations were passed in a consensus conference. The purpose of the guideline is to provide dermatologists with an evidence-based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.
Sujet(s)
Alopécie/thérapie , Médecine factuelle , Inhibiteurs de la 5-alpha réductase/usage thérapeutique , Association de médicaments , Dutastéride/usage thérapeutique , Femelle , Finastéride/usage thérapeutique , Poils/transplantation , Humains , Photothérapie de faible intensité , Mâle , Minoxidil/usage thérapeutique , , Plasma riche en plaquettes , Guides de bonnes pratiques cliniques comme sujet , Vasodilatateurs/usage thérapeutiqueSujet(s)
Hydroquinones/effets indésirables , Ochronose/induit chimiquement , Ochronose/diagnostic , Troubles de la pigmentation/induit chimiquement , Troubles de la pigmentation/diagnostic , Agents éclaircissants pour la peau/effets indésirables , Cosmétiques , Diagnostic différentiel , Évolution de la maladie , Dermatoses faciales/induit chimiquement , Dermatoses faciales/diagnostic , Femelle , Humains , Adulte d'âge moyen , Pigmentation de la peau/effets des médicaments et des substances chimiquesRÉSUMÉ
Androgenetic alopecia (AGA) is the most common hair loss disorder, affecting both men and women. Due to the frequency and the often significant impairment of life perceived by the affected patients, competent advice, diagnosis and treatment is particularly important. As evidence-based guidelines on hair disorders are rare, a European consensus group was constituted to develop guidelines for the diagnostic evaluation and treatment of AGA. This S1 guideline for diagnostic evaluation of AGA in men, women and adolescents reviews the definition of AGA and presents expert opinion-based recommendations for sex-dependent steps in the diagnostic procedure.
